ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

HUTCHMED clinical trials

Also known as Chi-Med.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 119 studies whose lead sponsor is HUTCHMED or the company grouped under it. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare HUTCHMED with Merck and Nuvation Bio →

Pipeline: 8 programs

Each counted once: 8 with a study HUTCHMED leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of HUTCHMED’s own registered studies; HUTCHMED’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs HUTCHMED’s studies test, most open studies first — 23 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 13 more

Coming up

2 of HUTCHMED’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 1O
  13. N

Add all 2 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 119 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1311%Recruiting 12 · Not yet recruiting 1
  • Under way, not recruiting22%
  • Completed8067%
  • Stopped early1513%Terminated 12 · Withdrawn 3
  • Status unknown or other98%Status unknown 8 · No longer available 1

Phase

  • Phase 175
  • Phase 236
  • Phase 322
  • Early Phase 12

Where

  • China80
  • United States32
  • Australia8
  • Spain8
  • Italy6
  • France5

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14
  8. 15
  9. 16
  10. 17
  11. 18
  12. 19
  13. 20
  14. 1721
  15. 22
  16. 23
  17. 24
  18. 25
  19. 526

By the year each study started; 1 started before 2008. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to HUTCHMED.

  • Hutchison Medipharma Limited
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    68 studies →
  • Hutchmed
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    51 studies

Related but not counted here: Shanghai Hutchison Pharmaceuticals Limited (affiliate).

Studies

Recruiting first, then most recently updated. Showing 50 of 119. Browse all 119 →